Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction
•Impaired orexin signaling is implicated in several neuropsychiatric conditions.•Intranasal orexin targets brain regions and neurotransmitters implicated in cognition.•The orexin-1 receptor mediates most, but not all, of these responses.•Intranasal orexin may be an effective, non-invasive means of c...
Saved in:
| Published in | Brain research Vol. 1731; p. 145921 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
15.03.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | •Impaired orexin signaling is implicated in several neuropsychiatric conditions.•Intranasal orexin targets brain regions and neurotransmitters implicated in cognition.•The orexin-1 receptor mediates most, but not all, of these responses.•Intranasal orexin may be an effective, non-invasive means of cognitive enhancement.
Cognitive impairment is a core feature of several neuropsychiatric and neurological disorders, including narcolepsy and age-related dementias. Current pharmacotherapeutic approaches to cognitive enhancement are few in number and limited in efficacy. Thus, novel treatment strategies are needed. The hypothalamic orexin (hypocretin) system, a central integrator of physiological function, plays an important role in modulating cognition. Several single- and dual-orexin receptor antagonists are available for various clinical and preclinical applications, but the paucity of orexin agonists has limited the ability to research their therapeutic potential. To circumvent this hurdle, direct intranasal administration of orexin peptides is being investigated as a prospective treatment for cognitive dysfunction, narcolepsy or other disorders in which deficient orexin signaling has been implicated. Here, we describe the possible mechanisms and therapeutic potential of intranasal orexin delivery. Combined with the behavioral evidence that intranasal orexin-A administration improves cognitive function in narcoleptic and sleep-deprived subjects, our neurochemical studies in young and aged animals highlights the capacity for intranasal orexin administration to improve age-related deficits in neurotransmission. In summary, we highlight prior and original work from our lab and from others that provides a framework for the use of intranasal orexin peptides in treating cognitive dysfunction, especially as it relates to age-related cognitive disorders. |
|---|---|
| AbstractList | Cognitive impairment is a core feature of several neuropsychiatric and neurological disorders, including narcolepsy and age-related dementias. Current pharmacotherapeutic approaches to cognitive enhancement are few in number and limited in efficacy. Thus, novel treatment strategies are needed. The hypothalamic orexin (hypocretin) system, a central integrator of physiological function, plays an important role in modulating cognition. Several single- and dual-orexin receptor antagonists are available for various clinical and preclinical applications, but the paucity of orexin agonists has limited the ability to research their therapeutic potential. To circumvent this hurdle, direct intranasal administration of orexin peptides is being investigated as a prospective treatment for cognitive dysfunction, narcolepsy or other disorders in which deficient orexin signaling has been implicated. Here, we describe the possible mechanisms and therapeutic potential of intranasal orexin delivery. Combined with the behavioral evidence that intranasal orexin-A administration improves cognitive function in narcoleptic and sleep-deprived subjects, our neurochemical studies in young and aged animals highlights the capacity for intranasal orexin administration to improve age-related deficits in neurotransmission. In summary, we highlight prior and original work from our lab and from others that provides a framework for the use of intranasal orexin peptides in treating cognitive dysfunction, especially as it relates to age-related cognitive disorders. •Impaired orexin signaling is implicated in several neuropsychiatric conditions.•Intranasal orexin targets brain regions and neurotransmitters implicated in cognition.•The orexin-1 receptor mediates most, but not all, of these responses.•Intranasal orexin may be an effective, non-invasive means of cognitive enhancement. Cognitive impairment is a core feature of several neuropsychiatric and neurological disorders, including narcolepsy and age-related dementias. Current pharmacotherapeutic approaches to cognitive enhancement are few in number and limited in efficacy. Thus, novel treatment strategies are needed. The hypothalamic orexin (hypocretin) system, a central integrator of physiological function, plays an important role in modulating cognition. Several single- and dual-orexin receptor antagonists are available for various clinical and preclinical applications, but the paucity of orexin agonists has limited the ability to research their therapeutic potential. To circumvent this hurdle, direct intranasal administration of orexin peptides is being investigated as a prospective treatment for cognitive dysfunction, narcolepsy or other disorders in which deficient orexin signaling has been implicated. Here, we describe the possible mechanisms and therapeutic potential of intranasal orexin delivery. Combined with the behavioral evidence that intranasal orexin-A administration improves cognitive function in narcoleptic and sleep-deprived subjects, our neurochemical studies in young and aged animals highlights the capacity for intranasal orexin administration to improve age-related deficits in neurotransmission. In summary, we highlight prior and original work from our lab and from others that provides a framework for the use of intranasal orexin peptides in treating cognitive dysfunction, especially as it relates to age-related cognitive disorders. Cognitive impairment is a core feature of several neuropsychiatric and neurological disorders, including narcolepsy and age-related dementias. Current pharmacotherapeutic approaches to cognitive enhancement are few in number and limited in efficacy. Thus, novel treatment strategies are needed. The hypothalamic orexin (hypocretin) system, a central integrator of physiological function, plays an important role in modulating cognition. Several single- and dual-orexin receptor antagonists are available for various clinical and preclinical applications, but the paucity of orexin agonists has limited the ability to research their therapeutic potential. To circumvent this hurdle, direct intranasal administration of orexin peptides is being investigated as a prospective treatment for cognitive dysfunction, narcolepsy or other disorders in which deficient orexin signaling has been implicated. Here, we describe the possible mechanisms and therapeutic potential of intranasal orexin delivery. Combined with the behavioral evidence that intranasal orexin-A administration improves cognitive function in narcoleptic and sleep-deprived subjects, our neurochemical studies in young and aged animals highlights the capacity for intranasal orexin administration to improve age-related deficits in neurotransmission. In summary, we highlight prior and original work from our lab and from others that provides a framework for the use of intranasal orexin peptides in treating cognitive dysfunction, especially as it relates to age-related cognitive disorders.Cognitive impairment is a core feature of several neuropsychiatric and neurological disorders, including narcolepsy and age-related dementias. Current pharmacotherapeutic approaches to cognitive enhancement are few in number and limited in efficacy. Thus, novel treatment strategies are needed. The hypothalamic orexin (hypocretin) system, a central integrator of physiological function, plays an important role in modulating cognition. Several single- and dual-orexin receptor antagonists are available for various clinical and preclinical applications, but the paucity of orexin agonists has limited the ability to research their therapeutic potential. To circumvent this hurdle, direct intranasal administration of orexin peptides is being investigated as a prospective treatment for cognitive dysfunction, narcolepsy or other disorders in which deficient orexin signaling has been implicated. Here, we describe the possible mechanisms and therapeutic potential of intranasal orexin delivery. Combined with the behavioral evidence that intranasal orexin-A administration improves cognitive function in narcoleptic and sleep-deprived subjects, our neurochemical studies in young and aged animals highlights the capacity for intranasal orexin administration to improve age-related deficits in neurotransmission. In summary, we highlight prior and original work from our lab and from others that provides a framework for the use of intranasal orexin peptides in treating cognitive dysfunction, especially as it relates to age-related cognitive disorders. |
| ArticleNumber | 145921 |
| Author | Calva, Coleman B. Fadel, Jim R. |
| AuthorAffiliation | 1 Department of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, 6311 Garners Ferry Road, Columbia, South Carolina, 29209, USA |
| AuthorAffiliation_xml | – name: 1 Department of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, 6311 Garners Ferry Road, Columbia, South Carolina, 29209, USA |
| Author_xml | – sequence: 1 givenname: Coleman B. surname: Calva fullname: Calva, Coleman B. – sequence: 2 givenname: Jim R. surname: Fadel fullname: Fadel, Jim R. email: jim.fadel@uscmed.sc.edu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30148983$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkk9vEzEQxS1URNPCV6h85LLBf9a7XoQqqgpopSIucLYcezZx2LUX24mab49Dmgp6KdJI1sjv_Z484zN04oMHhC4omVNCm3fr-SJq5yOkOSNUzkkpVr9AMypbVjWsJidoRghpKtl1_BSdpbQuLecdeYVOOaG17CSfoftbn6P2OukBazs671Lpswsehx6HCPfO4wmm7Cyk9_grmJUumjFh7S3OK4h6gk12Bk8hg8-ucPoQsV5CFWHQGSw2YelddlvAdpf6jTd7_Gv0stdDgjcP5zn68fnT9-ub6u7bl9vrq7vKCNbkClqumaCd7mrWs74VRvDa2oZaQbll1EqxAADRd1RaaEUrgGu5kE3f2W5hDT9HlwfutFmMYA3s3zuoKbpRx50K2ql_b7xbqWXYqobLVjZNAbx9AMTwawMpq9ElA8OgPYRNUox0QtSMtW2RXvyd9RhyHHcRfDgITAwpReiVcfnPtEu0GxQlar9dtVbH7ar9dhUpxepib57YjwnPGj8ejFAmvXUQVTIOvAHrIpisbHDPIy6fIMxQfovRw0_Y_Q_gN0My3Y8 |
| CitedBy_id | crossref_primary_10_1016_j_neulet_2024_137914 crossref_primary_10_1038_s41598_019_44450_6 crossref_primary_10_1016_j_physbeh_2021_113370 crossref_primary_10_1038_s41386_024_02017_8 crossref_primary_10_1111_joim_13406 crossref_primary_10_30773_pi_2020_0136 crossref_primary_10_1002_hipo_23376 crossref_primary_10_3389_fmed_2024_1463976 crossref_primary_10_1111_gbb_12707 crossref_primary_10_4103_bc_bc_42_19 crossref_primary_10_2147_NSS_S347658 crossref_primary_10_1016_j_npep_2021_102182 crossref_primary_10_1097_CCE_0000000000000349 crossref_primary_10_1124_pharmrev_123_000953 crossref_primary_10_3390_ijms23052857 crossref_primary_10_3389_fendo_2023_1266806 crossref_primary_10_1038_s41386_021_01052_z crossref_primary_10_3389_fnagi_2019_00362 |
| Cites_doi | 10.1152/jn.00927.2005 10.1002/cne.20369 10.1523/JNEUROSCI.3235-13.2014 10.1016/j.neurobiolaging.2010.12.014 10.1016/j.neuroscience.2004.09.050 10.1016/j.neulet.2009.10.061 10.1016/0163-1047(92)90276-A 10.1016/j.addr.2011.11.002 10.1002/cne.23290 10.1016/j.neuroscience.2008.01.013 10.1016/j.neurobiolaging.2011.03.014 10.1073/pnas.86.5.1698 10.1111/j.1365-2869.2006.00533.x 10.1523/JNEUROSCI.18-23-09996.1998 10.1016/j.neurobiolaging.2006.11.014 10.1016/j.bbr.2013.12.045 10.1016/j.brainres.2009.08.046 10.1016/B978-0-444-59489-1.00010-0 10.1007/s00213-015-4139-z 10.1016/S0278-5846(97)00077-8 10.1097/00000542-200605000-00019 10.1523/JNEUROSCI.2751-04.2004 10.1016/j.neurobiolaging.2006.05.025 10.1038/tp.2012.43 10.1016/j.tins.2013.11.004 10.1523/JNEUROSCI.3878-07.2007 10.1002/jps.21604 10.1111/bph.12296 10.1016/S0092-8674(00)80949-6 10.1093/gerona/54.11.B492 10.1111/j.1748-1716.2009.02021.x 10.1111/bph.12415 10.1093/cercor/7.6.476 10.1016/j.arr.2003.10.003 10.1002/cne.22229 10.1016/j.tins.2013.04.005 10.1016/S0960-894X(02)00851-X 10.1021/acs.jmedchem.5b00832 10.1124/mi.8.3.5 10.1073/pnas.95.1.322 10.1016/S0022-3565(24)38126-1 10.1126/science.1180962 10.1016/j.neuroscience.2004.05.029 10.1016/j.neuron.2006.01.016 10.1016/j.neuroscience.2009.05.043 10.1038/sj.npp.1300807 10.1523/JNEUROSCI.6506-10.2011 10.1007/s40263-012-0036-8 10.1002/cne.20859 10.1126/science.1255263 10.1016/S1389-9457(02)00156-9 10.1002/cmdc.201300003 10.1007/7854_2016_44 10.1016/j.neuroscience.2011.08.033 10.1523/JNEUROSCI.4622-09.2010 10.1093/sleep/26.8.953 10.1016/j.neulet.2016.05.053 10.1208/s12248-015-9719-7 10.1523/JNEUROSCI.22-17-07754.2002 10.1093/gerona/51A.1.B54 10.1038/srep12584 10.1016/j.neuroscience.2017.03.021 10.1016/S0006-8993(02)02240-0 10.1073/pnas.1413625112 10.1016/j.neuron.2005.03.010 10.1016/j.bbr.2007.05.033 10.1016/S0304-3940(02)00953-9 10.1002/cne.1190 10.1016/j.bmcl.2017.02.012 10.1016/j.neuron.2009.09.005 10.1093/brain/awn193 10.1038/nature07991 10.1016/j.neuroscience.2007.07.061 10.1002/hbm.23510 10.1038/sj.bjp.0703953 10.1093/brain/122.3.383 10.1186/2045-3701-3-19 10.1016/j.sleep.2010.07.004 10.1523/JNEUROSCI.0719-05.2005 10.1016/S0197-4580(03)00043-5 10.1124/jpet.102.048025 10.1016/S0306-4522(02)00017-9 10.4103/0976-0105.177703 10.1016/S0092-8674(00)81969-8 10.1111/j.1460-9568.2008.06029.x 10.1016/j.neulet.2011.02.055 10.1016/j.sleep.2011.06.015 10.1016/j.neulet.2014.03.020 10.1080/13543784.2018.1459561 10.1073/pnas.89.2.738 10.1007/7854_2016_50 10.1021/acs.jmedchem.5b00988 10.1159/000048633 10.1016/j.neulet.2006.01.065 10.1021/acs.molpharmaceut.5b00047 10.1093/sleep/32.8.993 10.1073/pnas.1700499114 10.3389/fnbeh.2017.00010 10.1016/S0163-7258(02)00171-7 10.1002/cne.10783 10.1002/jps.21924 10.1016/j.neuroscience.2004.05.012 10.1038/nrn894 10.1002/cne.10505 10.1016/j.neuroscience.2011.01.031 10.1002/(SICI)1096-9861(19991213)415:2<145::AID-CNE1>3.0.CO;2-2 |
| ContentType | Journal Article |
| Copyright | 2018 Elsevier B.V. Copyright © 2018 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2018 Elsevier B.V. – notice: Copyright © 2018 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1016/j.brainres.2018.08.024 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 1872-6240 |
| ExternalDocumentID | PMC6387866 30148983 10_1016_j_brainres_2018_08_024 S0006899318304463 |
| Genre | Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIA NIH HHS grantid: RF1 AG050518 – fundername: NIA NIH HHS grantid: R01 AG050518 |
| GroupedDBID | --- --K --M -DZ -~X .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 23N 4.4 457 4G. 5GY 5RE 6J9 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXLA AAXUO AAYWO ABCQJ ABFNM ABFRF ABIVO ABJNI ABLJU ABMAC ABTEW ACDAQ ACGFO ACGFS ACIUM ACNCT ACRLP ACVFH ADBBV ADCNI ADEZE AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFPUW AFRHN AFTJW AFXIZ AGCQF AGUBO AGWIK AGYEJ AIEXJ AIIUN AIKHN AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP AXJTR BKOJK BLXMC CS3 DU5 EBS EFJIC EFKBS EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W K-O KOM L7B M2V M41 MO0 MOBAO N9A O-L O9- OAUVE OP~ OZT P-8 P-9 P2P PC. Q38 ROL RPZ SCC SDF SDG SES SPCBC SSN SSZ T5K Z5R ZGI ~G- AACTN AADPK AAIAV ABYKQ AFCTW AFKWA AHHHB AJOXV AMFUW EFLBG .55 .GJ 41~ 53G 5VS AAQXK AAYJJ AAYXX ABWVN ABXDB ACRPL ADIYS ADMUD ADNMO AFJKZ AGHFR AGQPQ AGRNS AI. AIGII ASPBG AVWKF AZFZN BNPGV CITATION EJD FEDTE FGOYB G-2 HMQ HVGLF HZ~ MVM R2- RIG SEW SNS SSH VH1 WUQ X7M XPP CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c526t-e73a2519a942f2f75c534dd61d513d21d85beee5f918de7575e3a8b86f9d9bdc3 |
| IEDL.DBID | .~1 |
| ISSN | 0006-8993 1872-6240 |
| IngestDate | Thu Aug 21 18:01:15 EDT 2025 Fri Jul 11 10:58:53 EDT 2025 Mon Jul 21 05:56:03 EDT 2025 Thu Jul 10 10:00:18 EDT 2025 Thu Apr 24 23:10:17 EDT 2025 Fri Feb 23 02:48:32 EST 2024 Tue Aug 26 16:35:05 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | Copyright © 2018 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c526t-e73a2519a942f2f75c534dd61d513d21d85beee5f918de7575e3a8b86f9d9bdc3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/6387866 |
| PMID | 30148983 |
| PQID | 2095542277 |
| PQPubID | 23479 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6387866 proquest_miscellaneous_2095542277 pubmed_primary_30148983 crossref_citationtrail_10_1016_j_brainres_2018_08_024 crossref_primary_10_1016_j_brainres_2018_08_024 elsevier_sciencedirect_doi_10_1016_j_brainres_2018_08_024 elsevier_clinicalkey_doi_10_1016_j_brainres_2018_08_024 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-03-15 |
| PublicationDateYYYYMMDD | 2020-03-15 |
| PublicationDate_xml | – month: 03 year: 2020 text: 2020-03-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Brain research |
| PublicationTitleAlternate | Brain Res |
| PublicationYear | 2020 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Asahi, Egashira, Matsuda, Iwaasa, Kanatani, Ohkubo, Ihara, Morishima (b0010) 2003; 13 Gritti, Manns, Mainville, Jones (b0170) 2003; 458 Porkka-Heiskanen, Alanko, Kalinchuk, Heiskanen, Stenberg (b0375) 2004; 25 Baldo, Daniel, Berridge, Kelley (b0035) 2003; 464 Dong, Fukuda, Murata, Zhu, Higuchi (b0105) 2006; 104 Hassanpour, Simmons, Feinstein, Luo, Lapidus, Bodurka, Paulus, Khalsa (b0190) 2017 Weinhold, Goder, Baier (b0545) 2014; 23 Fadel, Pasumarthi, Reznikov (b0135) 2005; 130 Selbach, Bohla, Barbara, Doreulee, Eriksson, Sergeeva, Haas (b0430) 2010; 198 Marcus, Aschkenasi, Lee, Chemelli, Saper, Yanagisawa, Elmquist (b0315) 2001; 435 Dhuria, Hanson, Frey (b0085) 2009 Julliard, Chaput, Apelbaum, Aimé, Mahfouz, Duchamp-Viret (b0235) 2007; 183 Sakurai (b0400) 2002; 3 España, Reis, Valentino, Berridge (b0120) 2005; 481 Downs, Dunn, Borok, Shanabrough, Horvath, Kohama, Urbanski (b0110) 2007; 28 Kovács (b0280) 2004 Deadwyler, Porrino, Siegel, Hampson (b0080) 2007; 27 Li, Hu, de Lecea (b0295) 2014; 171 Nagahara, Saitoh, Kutsumura, Irukayama-Tomobe, Ogawa, Kuroda, Gouda, Kumagai, Fujii, Yanagisawa, Nagase (b0345) 2015; 58 Kawaguchi, Y., Kubota, Y., 1997. GABAergic Cell Subtypes and their Synaptic Connections in Rat Frontal Cortex 476–486. Lipman, Chrisp, Hazzard, Bronson (b0305) 1996; 51 Yang, McKenna, Zant, Winston, Basheer, Brown (b0570) 2014; 34 Hu, Gan, Jonas (b0205) 2014; 345 de Lecea, Kilduff, Peyron, Gao, Foye, Danielson, Fukuhara, Battenberg, Gautvik, Bartlett, Frankel, van den Pol, Bloom, Gautvik, Sutcliffe (b0075) 1998; 95 Sohrabi, Bates, Weinborn, Johnston, Bahramian, Taddei, Laws, Rodrigues, Morici, Howard, Martins, Mackay-Sim, Gandy, Martins (b0460) 2012; 2 Ammoun, Holmqvist, Shariatmadari, Oonk, Detheux, Parmentier, Akerman, Kukkonen (b0005) 2003; 305 Hagar, Macht, Wilson, Fadel (b0175) 2017; 350 Smart, Jerman (b0445) 2002 Kang, Lim, Bateman, Lee, Smyth, Cirrito, Fujiki, Nishino, Holtzman (b0245) 2009; 326 Mieda, Sakurai (b0335) 2013 Stettler, Axel (b0490) 2009; 63 Dhuria, Fine, Bingham, Svitak, Burns, Baillargeon, Panter, Kazi, Frey, Hanson (b0095) 2016; 627 Dhuria, Hanson, Frey (b0090) 2010; 99 Selbach, Doreulee, Bohla, Eriksson, Sergeeva, Poelchen, Brown, Haas (b0425) 2004; 127 Djordjevic, Jones-Gotman, De Sousa, Chertkow (b0100) 2008; 29 Villano, Messina, Valenzano, Moscatelli, Esposito, Monda, Esposito, Precenzano, Carotenuto, Viggiano, Chieffi, Cibelli, Monda, Messina (b0535) 2017; 11 Wu, Zhang, Leranth, Xu, van den Pol, Alreja (b0560) 2002; 22 Putula, Turunen, Jantti, Ekholm, Kukkonen (b0385) 2011; 494 Sakurai, Amemiya, Ishii, Matsuzaki, Chemelli, Tanaka, Williams, Richardson, Kozlowski, Wilson, Arch, Buckingham, Haynes, Carr, Annan, McNulty, Liu, Terrett, Elshourbagy, Bergsma, Yanagisawa (b0405) 1998; 92 Hallschmid, Born (b0180) 2008 Baier, Hallschmid, Seeck-Hirschner, Weinhold, Burkert, Diessner, Göder, Aldenhoff, Hinze-Selch (b0025) 2011; 12 Fadel, Burk (b0125) 2010; 1314 Kasanuki, Iseki, Kondo, Fujishiro, Minegishi, Sato, Katsuse, Hino, Kosaka, Arai (b0250) 2014; 569 Stanley, Fadel (b0475) 2011; 195 Fronczek, van Geest, Frölich, Overeem, Roelandse, Lammers, Swaab (b0150) 2012; 33 Siegel (b0435) 1999 Sarter, Turchi (b0415) 2002 Lochhead, Thorne (b0310) 2012; 64 Irukayama-Tomobe, Ogawa, Tominaga, Ishikawa, Hosokawa, Ambai, Kawabe, Uchida, Nakajima, Saitoh, Kanda, Vogt, Sakurai, Nagase, Yanagisawa (b0220) 2017; 114 Xu, Roby, Callaway (b0565) 2010; 518 John, Wu, Siegel (b0225) 2000; 3 Rieger, Mayer, Gauggel (b0390) 2003; 26 Roecker, Cox, Coleman (b0395) 2016; 59 Turturro, Witt, Lewis, Hass, Lipman, Hart (b0530) 1999; 54 Steiner, Gatfield, Brisbare-Roch, Dietrich, Treiber, Jenck, Boss (b0485) 2013; 8 Horvath, Peyron, Diano, Ivanov, Aston-Jones, Kilduff, Van Den Pol (b0200) 1999; 415 Nair, Jacob (b0350) 2016; 7 Fujiki, Yoshida, Ripley, Mignot, Nishino (b0155) 2003; 26 Peyron, Tighe, van den Pol, de Lecea, Heller, Sutcliffe, Kilduff (b0370) 1998; 18 Borgland, Taha, Sarti, Fields, Bonci (b0050) 2006; 49 Fadel, Deutch (b0130) 2002; 111 Stanley, Fadel, Mott (b0480) 2012; 33 Paxinos, Watson (b0360) 1998 Enwere (b0115) 2004; 24 Kelsom, Lu (b0265) 2013; 3 Turku, Rinne, Boije Af Gennäs, Xhaard, Lindholm, Kukkonen (b0525) 2017 Sawai, Ueta, Nakazato, Ozawa (b0420) 2010; 468 Henny, Jones (b0195) 2008; 27 Avery, Gotts, Kerr, Burrows, Ingeholm, Bodurka, Martin, Kyle Simmons (b0015) 2017; 38 Freund, Meskenaite (b0145) 1992; 89 Frederick-Duus, Guyton, Fadel (b0140) 2007; 149 Skudlarek, DiMarco, Babaoglu, Roecker, Bruno, Pausch, O’Brien, Cabalu, Stevens, Brunner, Tannenbaum, Wuelfing, Garson, Fox, Savitz, Harrell, Gotter, Winrow, Renger, Kuduk, Coleman (b0440) 2017; 27 Perry, Hodges (b0365) 1999; 122 Chieffi, Carotenuto, Monda, Valenzano, Villano, Precenzano, Tafuri, Salerno, Filippi, Nuccio, Ruberto, Luca, Cipolloni, Cibelli, Mollica, Iacono, Nigro, Monda, Messina, Messina1 (b0060) 2017 Terao, Apte-Deshpande, Morairty, Freund, Kilduff (b0500) 2002; 332 Wesson, Levy, Nixon, Wilson (b0555) 2010; 30 Baimel, Borgland (b0030) 2017; 33 Sakurai, Nagata, Yamanaka, Kawamura, Tsujino, Muraki, Kageyama, Kunita, Takahashi, Goto, Koyama, Shioda, Yanagisawa (b0410) 2005; 46 Takenoshita, Sakai, Chiba, Matsumura, Yamaguchi, Nishino (b0495) 2018; 27 Thorne, Hanson, Ross, Tung, Frey (b0515) 2008; 152 Calva, Fayyaz, Fadel (b0055) 2017 Mieda, Hasegawa, Kisanuki, Sinton, Yanagisawa, Sakurai (b0330) 2011; 31 Yoshida, McCormack, España, Crocker, Scammell (b0575) 2006; 494 Thannickal, Nienhuis, Siegel (b0505) 2009; 32 Weinhold, Seeck-Hirschner, Nowak, Hallschmid, Göder, Baier (b0550) 2014; 262 Davies, Chen, Pink, Carter, Saunders, Sotiriadis, Bai, Pan, Howlett, Payne, Randeva, Karteris (b0070) 2015; 5 Sohal, Zhang, Yizhar, Deisseroth (b0455) 2009; 459 Kim, Thankachan, McKenna, McNally, Yang, Choi, Chen, Kocsis, Deisseroth, Strecker, Basheer, Brown, McCarley (b0275) 2015; 112 Tiitinen, May, Näätänen (b0520) 1997 Meredith, Salameh, Banks (b0325) 2015; 17 Leonard, Kukkonen (b0290) 2014 Bayard, Plazzi, Poli, Serra, Ferri, Dauvilliers (b0040) 2010; 11 Craig, Craig (b0065) 2002; 3 Hüttenbrink, Hummel, Berg, Gasser, Hähner (b0215) 2013; 110 Vittoz, Berridge (b0540) 2006; 31 Hanson, Frey (b0185) 2008 Kastin, Akerstrom (b0255) 1999; 289 Kessler, Stanley, Frederick-Duus, Fadel (b0270) 2011; 178 Jones (b0230) 2008; 1129 Huang, Ghosh, van den Pol (b0210) 2006; 95 Kaczmarek (b0240) 1992; 57 Naumann, Bellebaum, Daum (b0355) 2006; 15 Liguori (b0300) 2017; 33 Spetter, Hallschmid (b0470) 2015; 12 Mckenna, Yang, Franciosi, Winston, Abarr, Rigby, Yanagawa, Mccarley, Brown (b0320) 2013; 521 Bekkers, Suzuki (b0045) 2013 Zhang, Sampogna, Morales, Chase (b0585) 2002; 930 Gotter, Roecker, Hargreaves, Coleman, Winrow, Renger (b0160) 2012; 198 Song, Chen, Xia, Yu, Hu (b0465) 2006; 399 Lambe, Olausson, Horst, Taylor, Aghajanian (b0285) 2005; 25 Thorne, Pronk, Padmanabhan, Frey (b0510) 2004; 127 Gray, Singer (b0165) 1989; 86 Mobley, Rodriguez-Gil, Imamura, Greer (b0340) 2014 Prud’homme, Lacroix, Badonnel, Gougis, Baly, Salesse, Caillol (b0380) 2009; 162 Zajo, Fadel, Burk (b0580) 2016; 233 Baier, Weinhold, Huth, Gottwald, Ferstl, Hinze-Selch (b0020) 2008; 131 Smart, Sabido-David, Brough, Jewitt, Johns, Porter, Jerman (b0450) 2001; 132 Huang (10.1016/j.brainres.2018.08.024_b0210) 2006; 95 Mieda (10.1016/j.brainres.2018.08.024_b0335) 2013 Sawai (10.1016/j.brainres.2018.08.024_b0420) 2010; 468 Horvath (10.1016/j.brainres.2018.08.024_b0200) 1999; 415 Thannickal (10.1016/j.brainres.2018.08.024_b0505) 2009; 32 Thorne (10.1016/j.brainres.2018.08.024_b0510) 2004; 127 Hanson (10.1016/j.brainres.2018.08.024_b0185) 2008 Davies (10.1016/j.brainres.2018.08.024_b0070) 2015; 5 Fadel (10.1016/j.brainres.2018.08.024_b0130) 2002; 111 Sohrabi (10.1016/j.brainres.2018.08.024_b0460) 2012; 2 Perry (10.1016/j.brainres.2018.08.024_b0365) 1999; 122 Bekkers (10.1016/j.brainres.2018.08.024_b0045) 2013 Djordjevic (10.1016/j.brainres.2018.08.024_b0100) 2008; 29 Lipman (10.1016/j.brainres.2018.08.024_b0305) 1996; 51 Yoshida (10.1016/j.brainres.2018.08.024_b0575) 2006; 494 Zajo (10.1016/j.brainres.2018.08.024_b0580) 2016; 233 Julliard (10.1016/j.brainres.2018.08.024_b0235) 2007; 183 Yang (10.1016/j.brainres.2018.08.024_b0570) 2014; 34 Dhuria (10.1016/j.brainres.2018.08.024_b0090) 2010; 99 Terao (10.1016/j.brainres.2018.08.024_b0500) 2002; 332 Kasanuki (10.1016/j.brainres.2018.08.024_b0250) 2014; 569 Turturro (10.1016/j.brainres.2018.08.024_b0530) 1999; 54 Hu (10.1016/j.brainres.2018.08.024_b0205) 2014; 345 Porkka-Heiskanen (10.1016/j.brainres.2018.08.024_b0375) 2004; 25 Baier (10.1016/j.brainres.2018.08.024_b0020) 2008; 131 Gritti (10.1016/j.brainres.2018.08.024_b0170) 2003; 458 Lochhead (10.1016/j.brainres.2018.08.024_b0310) 2012; 64 Spetter (10.1016/j.brainres.2018.08.024_b0470) 2015; 12 Nair (10.1016/j.brainres.2018.08.024_b0350) 2016; 7 Kastin (10.1016/j.brainres.2018.08.024_b0255) 1999; 289 Song (10.1016/j.brainres.2018.08.024_b0465) 2006; 399 Marcus (10.1016/j.brainres.2018.08.024_b0315) 2001; 435 Stanley (10.1016/j.brainres.2018.08.024_b0480) 2012; 33 Smart (10.1016/j.brainres.2018.08.024_b0450) 2001; 132 Vittoz (10.1016/j.brainres.2018.08.024_b0540) 2006; 31 Sakurai (10.1016/j.brainres.2018.08.024_b0410) 2005; 46 Zhang (10.1016/j.brainres.2018.08.024_b0585) 2002; 930 Sakurai (10.1016/j.brainres.2018.08.024_b0405) 1998; 92 Xu (10.1016/j.brainres.2018.08.024_b0565) 2010; 518 Kim (10.1016/j.brainres.2018.08.024_b0275) 2015; 112 España (10.1016/j.brainres.2018.08.024_b0120) 2005; 481 Ammoun (10.1016/j.brainres.2018.08.024_b0005) 2003; 305 Fujiki (10.1016/j.brainres.2018.08.024_b0155) 2003; 26 de Lecea (10.1016/j.brainres.2018.08.024_b0075) 1998; 95 Hüttenbrink (10.1016/j.brainres.2018.08.024_b0215) 2013; 110 Skudlarek (10.1016/j.brainres.2018.08.024_b0440) 2017; 27 Villano (10.1016/j.brainres.2018.08.024_b0535) 2017; 11 Putula (10.1016/j.brainres.2018.08.024_b0385) 2011; 494 Naumann (10.1016/j.brainres.2018.08.024_b0355) 2006; 15 Wu (10.1016/j.brainres.2018.08.024_b0560) 2002; 22 Dong (10.1016/j.brainres.2018.08.024_b0105) 2006; 104 Meredith (10.1016/j.brainres.2018.08.024_b0325) 2015; 17 Sakurai (10.1016/j.brainres.2018.08.024_b0400) 2002; 3 Stanley (10.1016/j.brainres.2018.08.024_b0475) 2011; 195 Sohal (10.1016/j.brainres.2018.08.024_b0455) 2009; 459 Henny (10.1016/j.brainres.2018.08.024_b0195) 2008; 27 Kovács (10.1016/j.brainres.2018.08.024_b0280) 2004 Jones (10.1016/j.brainres.2018.08.024_b0230) 2008; 1129 Smart (10.1016/j.brainres.2018.08.024_b0445) 2002 Selbach (10.1016/j.brainres.2018.08.024_b0425) 2004; 127 Kelsom (10.1016/j.brainres.2018.08.024_b0265) 2013; 3 10.1016/j.brainres.2018.08.024_b0260 Paxinos (10.1016/j.brainres.2018.08.024_b0360) 1998 Liguori (10.1016/j.brainres.2018.08.024_b0300) 2017; 33 Weinhold (10.1016/j.brainres.2018.08.024_b0545) 2014; 23 Roecker (10.1016/j.brainres.2018.08.024_b0395) 2016; 59 Steiner (10.1016/j.brainres.2018.08.024_b0485) 2013; 8 Dhuria (10.1016/j.brainres.2018.08.024_b0095) 2016; 627 Wesson (10.1016/j.brainres.2018.08.024_b0555) 2010; 30 Avery (10.1016/j.brainres.2018.08.024_b0015) 2017; 38 Craig (10.1016/j.brainres.2018.08.024_b0065) 2002; 3 Downs (10.1016/j.brainres.2018.08.024_b0110) 2007; 28 Sarter (10.1016/j.brainres.2018.08.024_b0415) 2002 Turku (10.1016/j.brainres.2018.08.024_b0525) 2017 Fadel (10.1016/j.brainres.2018.08.024_b0135) 2005; 130 Siegel (10.1016/j.brainres.2018.08.024_b0435) 1999 Frederick-Duus (10.1016/j.brainres.2018.08.024_b0140) 2007; 149 Bayard (10.1016/j.brainres.2018.08.024_b0040) 2010; 11 Gotter (10.1016/j.brainres.2018.08.024_b0160) 2012; 198 Lambe (10.1016/j.brainres.2018.08.024_b0285) 2005; 25 Dhuria (10.1016/j.brainres.2018.08.024_b0085) 2009 Baier (10.1016/j.brainres.2018.08.024_b0025) 2011; 12 John (10.1016/j.brainres.2018.08.024_b0225) 2000; 3 Enwere (10.1016/j.brainres.2018.08.024_b0115) 2004; 24 Rieger (10.1016/j.brainres.2018.08.024_b0390) 2003; 26 Prud’homme (10.1016/j.brainres.2018.08.024_b0380) 2009; 162 Kaczmarek (10.1016/j.brainres.2018.08.024_b0240) 1992; 57 Calva (10.1016/j.brainres.2018.08.024_b0055) 2017 Freund (10.1016/j.brainres.2018.08.024_b0145) 1992; 89 Hagar (10.1016/j.brainres.2018.08.024_b0175) 2017; 350 Fadel (10.1016/j.brainres.2018.08.024_b0125) 2010; 1314 Baimel (10.1016/j.brainres.2018.08.024_b0030) 2017; 33 Irukayama-Tomobe (10.1016/j.brainres.2018.08.024_b0220) 2017; 114 Leonard (10.1016/j.brainres.2018.08.024_b0290) 2014 Mieda (10.1016/j.brainres.2018.08.024_b0330) 2011; 31 Tiitinen (10.1016/j.brainres.2018.08.024_b0520) 1997 Weinhold (10.1016/j.brainres.2018.08.024_b0550) 2014; 262 Kessler (10.1016/j.brainres.2018.08.024_b0270) 2011; 178 Deadwyler (10.1016/j.brainres.2018.08.024_b0080) 2007; 27 Borgland (10.1016/j.brainres.2018.08.024_b0050) 2006; 49 Thorne (10.1016/j.brainres.2018.08.024_b0515) 2008; 152 Chieffi (10.1016/j.brainres.2018.08.024_b0060) 2017 Fronczek (10.1016/j.brainres.2018.08.024_b0150) 2012; 33 Nagahara (10.1016/j.brainres.2018.08.024_b0345) 2015; 58 Hassanpour (10.1016/j.brainres.2018.08.024_b0190) 2017 Kang (10.1016/j.brainres.2018.08.024_b0245) 2009; 326 Peyron (10.1016/j.brainres.2018.08.024_b0370) 1998; 18 Baldo (10.1016/j.brainres.2018.08.024_b0035) 2003; 464 Asahi (10.1016/j.brainres.2018.08.024_b0010) 2003; 13 Mckenna (10.1016/j.brainres.2018.08.024_b0320) 2013; 521 Mobley (10.1016/j.brainres.2018.08.024_b0340) 2014 Li (10.1016/j.brainres.2018.08.024_b0295) 2014; 171 Takenoshita (10.1016/j.brainres.2018.08.024_b0495) 2018; 27 Gray (10.1016/j.brainres.2018.08.024_b0165) 1989; 86 Stettler (10.1016/j.brainres.2018.08.024_b0490) 2009; 63 Hallschmid (10.1016/j.brainres.2018.08.024_b0180) 2008 Selbach (10.1016/j.brainres.2018.08.024_b0430) 2010; 198 |
| References_xml | – year: 2017 ident: b0190 article-title: The insular cortex dynamically maps changes in cardiorespiratory interoception publication-title: Neuropsychopharmacology – year: 1998 ident: b0360 article-title: The Rat Brain in Stereotaxic Coordinates – volume: 23 start-page: 291 year: 2014 ident: b0545 article-title: Improvement of divided attention in narcolepsy by intranasal orexin-A publication-title: J. Sleep Res. – volume: 122 start-page: 383 year: 1999 end-page: 404 ident: b0365 article-title: Attention and executive deficits in Alzheimer’s disease. A critical review publication-title: Brain – volume: 345 year: 2014 ident: b0205 article-title: Fast-spiking, parvalbumin+ GABAergic interneurons: from cellular design to microcircuit function publication-title: Science (80-.) – volume: 171 start-page: 332 year: 2014 end-page: 350 ident: b0295 article-title: The hypocretins/orexins: integrators of multiple physiological functions publication-title: Br. J. Pharmacol. – volume: 110 year: 2013 ident: b0215 article-title: Olfactory dysfunction: common in later life and early warning of neurodegenerative disease publication-title: Dtsch. Arztebl. Int. – volume: 25 start-page: 5225 year: 2005 end-page: 5229 ident: b0285 article-title: Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat publication-title: J. Neurosci. – volume: 7 start-page: 27 year: 2016 end-page: 31 ident: b0350 article-title: A simple practice guide for dose conversion between animals and human publication-title: J. Basic Clin. Pharm. – volume: 54 start-page: B492 year: 1999 end-page: B501 ident: b0530 article-title: Growth curves and survival characteristics of the animals used in the biomarkers of aging program publication-title: J. Gerontol. Ser. A Biol. Sci. Med. Sci. – volume: 481 start-page: 160 year: 2005 end-page: 178 ident: b0120 article-title: Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures publication-title: J. Comp. Neurol. – volume: 289 start-page: 219 year: 1999 end-page: 223 ident: b0255 article-title: Orexin A but not orexin B rapidly enters brain from blood by simple diffusion publication-title: J. Pharmacol. Exp. Ther. – year: 2009 ident: b0085 article-title: Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system publication-title: J. Pharm. Sci. – volume: 27 start-page: 654 year: 2008 end-page: 670 ident: b0195 article-title: Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons publication-title: Eur. J. Neurosci. – volume: 468 start-page: 51 year: 2010 end-page: 55 ident: b0420 article-title: Developmental and aging change of orexin-A and -B immunoreactive neurons in the male rat hypothalamus publication-title: Neurosci. Lett. – year: 1999 ident: b0435 article-title: Narcolepsy: a key role for hypocretins (Orexins) publication-title: Cell – year: 2002 ident: b0445 article-title: The physiology and pharmacology of the orexins publication-title: Pharmacol. Ther. – volume: 26 start-page: 36 year: 2003 end-page: 43 ident: b0390 article-title: Attention deficits in patients with narcolepsy publication-title: Sleep – volume: 131 start-page: 2734 year: 2008 end-page: 2741 ident: b0020 article-title: Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1) publication-title: Brain – volume: 12 start-page: 2767 year: 2015 end-page: 2780 ident: b0470 article-title: Intranasal neuropeptide administration to target the human brain in health and disease publication-title: Mol. Pharm. – volume: 38 start-page: 2150 year: 2017 end-page: 2164 ident: b0015 article-title: Convergent gustatory and viscerosensory processing in the human dorsal mid-insula publication-title: Hum. Brain Mapp. – volume: 930 start-page: 206 year: 2002 end-page: 211 ident: b0585 article-title: Age-related changes in hypocretin (orexin) immunoreactivity in the cat brainstem publication-title: Brain Res. – volume: 30 start-page: 505 year: 2010 end-page: 514 ident: b0555 article-title: Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer’s disease mouse model publication-title: J. Neurosci. – volume: 28 start-page: 1286 year: 2007 end-page: 1295 ident: b0110 article-title: Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque publication-title: Neurobiol. Aging – volume: 2 year: 2012 ident: b0460 article-title: Olfactory discrimination predicts cognitive decline among community-dwelling older adults publication-title: Transl. Psychiatry – volume: 435 start-page: 6 year: 2001 end-page: 25 ident: b0315 article-title: Differential expression of orexin receptors 1 and 2 in the rat brain publication-title: J. Comp. Neurol. – volume: 99 start-page: 1654 year: 2010 end-page: 1673 ident: b0090 article-title: Intranasal delivery to the central nervous system: mechanisms and experimental considerations publication-title: J. Pharm. Sci. – year: 2013 ident: b0335 article-title: Orexin (Hypocretin) receptor agonists and antagonists for treatment of sleep disorders: rationale for development and current status publication-title: CNS Drugs – volume: 130 start-page: 541 year: 2005 end-page: 547 ident: b0135 article-title: Stimulation of cortical acetylcholine release by orexin A publication-title: Neuroscience – volume: 57 start-page: 263 year: 1992 end-page: 266 ident: b0240 article-title: Expression of c-fos and other genes encoding transcription factors in long-term potentiation. [Review] publication-title: Behav. Neural Biol. – volume: 3 start-page: 23 year: 2000 end-page: 28 ident: b0225 article-title: Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs publication-title: Sleep Res. Online – year: 1997 ident: b0520 article-title: The transient 40-Hz response, mismatch negativity, and attentional processes in humans publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatry – volume: 415 start-page: 145 year: 1999 end-page: 159 ident: b0200 article-title: Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system publication-title: J. Comp. Neurol. – year: 2008 ident: b0180 article-title: Revealing the potential of intranasally administered orexin A publication-title: Mol. Interventions – volume: 33 year: 2012 ident: b0480 article-title: Interneuron loss reduces dendritic inhibition and GABA release in hippocampus of aged rats publication-title: Neurobiol. Aging – volume: 33 start-page: 283 year: 2017 end-page: 304 ident: b0030 article-title: Hypocretin/orexin and plastic adaptations associated with drug abuse publication-title: Curr. Top. Behav. Neurosci. – volume: 494 start-page: 845 year: 2006 end-page: 861 ident: b0575 article-title: Afferents to the orexin neurons of the rat brain publication-title: J. Comp. Neurol. – volume: 11 start-page: 876 year: 2010 end-page: 881 ident: b0040 article-title: Olfactory dysfunction in narcolepsy with cataplexy publication-title: Sleep Med. – volume: 15 start-page: 329 year: 2006 end-page: 338 ident: b0355 article-title: Cognitive deficits in narcolepsy publication-title: J. Sleep Res. – volume: 31 start-page: 384 year: 2006 end-page: 395 ident: b0540 article-title: Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area publication-title: Neuropsychopharmacology – volume: 305 start-page: 507 year: 2003 end-page: 514 ident: b0005 article-title: Distinct recognition of OX1 and OX2 receptors by orexin peptides publication-title: J. Pharmacol. Exp. Ther. – volume: 399 start-page: 101 year: 2006 end-page: 105 ident: b0465 article-title: Modulatory effects of hypocretin-1/orexin-A with glutamate and gamma-aminobutyric acid on freshly isolated pyramidal neurons from the rat prefrontal cortex publication-title: Neurosci. Lett. – volume: 49 start-page: 589 year: 2006 end-page: 601 ident: b0050 article-title: Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine publication-title: Neuron – volume: 459 start-page: 698 year: 2009 end-page: 702 ident: b0455 article-title: Parvalbumin neurons and gamma rhythms enhance cortical circuit performance publication-title: Nature – volume: 350 start-page: 124 year: 2017 end-page: 132 ident: b0175 article-title: Upregulation of orexin/hypocretin expression in aged rats: Effects on feeding latency and neurotransmission in the insular cortex publication-title: Neuroscience – volume: 58 start-page: 7931 year: 2015 end-page: 7937 ident: b0345 article-title: Design and synthesis of non-peptide, selective orexin receptor 2 agonists publication-title: J. Med. Chem. – volume: 1314 start-page: 112 year: 2010 end-page: 123 ident: b0125 article-title: Orexin/hypocretin modulation of the basal forebrain cholinergic system: role in attention publication-title: Brain Res. – volume: 11 year: 2017 ident: b0535 article-title: Basal forebrain cholinergic system and orexin neurons: effects on attention publication-title: Front. Behav. Neurosci. – volume: 569 start-page: 68 year: 2014 end-page: 73 ident: b0250 article-title: Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies publication-title: Neurosci. Lett. – volume: 33 start-page: 305 year: 2017 end-page: 322 ident: b0300 article-title: Orexin and Alzheimer’s disease publication-title: Curr. Top. Behav. Neurosci. – volume: 17 start-page: 780 year: 2015 end-page: 787 ident: b0325 article-title: Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases publication-title: AAPS J. – volume: 32 start-page: 993 year: 2009 end-page: 998 ident: b0505 article-title: Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy publication-title: Sleep – volume: 132 start-page: 1179 year: 2001 end-page: 1182 ident: b0450 article-title: SB-334867-A: the first selective orexin-1 receptor antagonist publication-title: Br. J. Pharmacol. – year: 2013 ident: b0045 article-title: Neurons and circuits for odor processing in the piriform cortex publication-title: Trends Neurosci. – volume: 95 start-page: 322 year: 1998 end-page: 327 ident: b0075 article-title: The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 326 start-page: 1005 year: 2009 end-page: 1007 ident: b0245 article-title: Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle publication-title: Science – reference: Kawaguchi, Y., Kubota, Y., 1997. GABAergic Cell Subtypes and their Synaptic Connections in Rat Frontal Cortex 476–486. – volume: 59 start-page: 504 year: 2016 end-page: 530 ident: b0395 article-title: Orexin receptor antagonists: new therapeutic agents for the treatment of insomnia publication-title: J. Med. Chem. – volume: 22 start-page: 7754 year: 2002 end-page: 7765 ident: b0560 article-title: Hypocretin increases impulse flow in the septohippocampal GABAergic pathway: implications for arousal via a mechanism of hippocampal disinhibition publication-title: J. Neurosci. – volume: 24 start-page: 8354 year: 2004 end-page: 8365 ident: b0115 article-title: Aging results in reduced epidermal growth factor receptor signaling, diminished olfactory neurogenesis, and deficits in fine olfactory discrimination publication-title: J. Neurosci. – volume: 33 start-page: 1642 year: 2012 end-page: 1650 ident: b0150 article-title: Hypocretin (orexin) loss in Alzheimer’s disease publication-title: Neurobiol. Aging – volume: 198 start-page: 277 year: 2010 end-page: 285 ident: b0430 article-title: Orexins/hypocretins control bistability of hippocampal long-term synaptic plasticity through co-activation of multiple kinases publication-title: Acta Physiol. (Oxf) – volume: 13 start-page: 111 year: 2003 end-page: 113 ident: b0010 article-title: Development of an orexin-2 receptor selective agonist, [Ala11, D-Leu15]orexin-B publication-title: Bioorg. Med. Chem. Lett. – volume: 104 start-page: 1023 year: 2006 end-page: 1032 ident: b0105 article-title: Orexins increase cortical acetylcholine release and electroencephalographic activation through orexin-1 receptor in the rat basal forebrain during isoflurane anesthesia publication-title: Anesthesiology – volume: 198 start-page: 163 year: 2012 end-page: 188 ident: b0160 article-title: Orexin receptors as therapeutic drug targets publication-title: Prog. Brain Res. – volume: 233 start-page: 639 year: 2016 end-page: 647 ident: b0580 article-title: Orexin A-induced enhancement of attentional processing in rats: role of basal forebrain neurons publication-title: Psychopharmacology – volume: 27 start-page: 14239 year: 2007 end-page: 14247 ident: b0080 article-title: Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates publication-title: J. Neurosci. – volume: 112 start-page: 3535 year: 2015 end-page: 3540 ident: b0275 article-title: Cortically projecting basal forebrain parvalbumin neurons regulate cortical gamma band oscillations publication-title: Proc. Natl. Acad. Sci. – volume: 51 start-page: B54 year: 1996 end-page: B59 ident: b0305 article-title: Pathologic characterization of brown Norway, brown Norway x Fischer 344, and Fischer 344 x brown Norway rats with relation to age publication-title: J. Gerontol. A Biol. Sci. Med. Sci. – year: 2017 ident: b0060 article-title: Orexin system: the key for a healthy life publication-title: Front. Neurol. – volume: 458 start-page: 11 year: 2003 end-page: 31 ident: b0170 article-title: Parvalbumin, calbindin, or calretinin in cortically projecting and GABAergic, cholinergic, or glutamatergic basal forebrain neurons of the rat publication-title: J. Comp. Neurol. – volume: 627 start-page: 155 year: 2016 end-page: 159 ident: b0095 article-title: Food consumption and activity levels increase in rats following intranasal Hypocretin-1 publication-title: Neurosci. Lett. – volume: 178 start-page: 82 year: 2011 end-page: 88 ident: b0270 article-title: Age-related loss of orexin/hypocretin neurons publication-title: Neuroscience – volume: 27 start-page: 1364 year: 2017 end-page: 1370 ident: b0440 article-title: Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists publication-title: Bioorg. Med. Chem. Lett. – volume: 111 start-page: 379 year: 2002 end-page: 387 ident: b0130 article-title: Anatomical substrates of orexin-dopamine interactions: Lateral hypothalamic projections to the ventral tegmental area publication-title: Neuroscience – volume: 3 start-page: 655 year: 2002 end-page: 666 ident: b0065 article-title: How do you feel? Interoception: the sense of the physiological condition of the body publication-title: Nat. Rev. Neurosci. – volume: 114 start-page: 5731 year: 2017 end-page: 5736 ident: b0220 article-title: Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 3 start-page: 19 year: 2013 ident: b0265 article-title: Development and specification of GABAergic cortical interneurons publication-title: Cell Biosci. – volume: 27 start-page: 389 year: 2018 end-page: 406 ident: b0495 article-title: An overview of hypocretin based therapy in narcolepsy publication-title: Expert Opin. Invest. Drugs – volume: 31 start-page: 6518 year: 2011 end-page: 6526 ident: b0330 article-title: Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep publication-title: J. Neurosci. – volume: 26 start-page: 953 year: 2003 end-page: 959 ident: b0155 article-title: Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog publication-title: Sleep – volume: 464 start-page: 220 year: 2003 end-page: 237 ident: b0035 article-title: Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress publication-title: J. Comp. Neurol. – year: 2014 ident: b0290 article-title: Orexin/hypocretin receptor signalling: a functional perspective publication-title: Br. J. Pharmacol. – year: 2002 ident: b0415 article-title: Age- and dementia-associated impairments in divided attention: psychological constructs, animal models, and underlying neuronal mechanisms publication-title: Dement. Geriatr. Cogn. Disord. – volume: 162 start-page: 1287 year: 2009 end-page: 1298 ident: b0380 article-title: Nutritional status modulates behavioural and olfactory bulb Fos responses to isoamyl acetate or food odour in rats: roles of orexins and leptin publication-title: Neuroscience – volume: 127 start-page: 519 year: 2004 end-page: 528 ident: b0425 article-title: Orexins/hypocretins cause sharp wave- and θ-related synaptic plasticity in the hippocampus via glutamatergic, gabaergic, noradrenergic, and cholinergic signaling publication-title: Neuroscience – volume: 149 start-page: 499 year: 2007 end-page: 507 ident: b0140 article-title: Food-elicited increases in cortical acetylcholine release require orexin transmission publication-title: Neuroscience – volume: 1129 start-page: 26 year: 2008 end-page: 34 ident: b0230 article-title: Modulation of cortical activation and behavioral arousal by cholinergic and orexinergic systems publication-title: Mol. Biophys. Mech. Arousal, Alertness, Atten. – volume: 5 start-page: 12584 year: 2015 ident: b0070 article-title: Orexin receptors exert a neuroprotective effect in Alzheimer’s disease (AD) via heterodimerization with GPR103 publication-title: Sci. Rep. – volume: 127 start-page: 481 year: 2004 end-page: 496 ident: b0510 article-title: Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration publication-title: Neuroscience – volume: 521 start-page: 1225 year: 2013 end-page: 1250 ident: b0320 article-title: Distribution and intrinsic membrane properties of basal forebrain GABAergic and parvalbumin neurons in the mouse publication-title: J. Comp. Neurol. – volume: 12 start-page: 941 year: 2011 end-page: 946 ident: b0025 article-title: Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy publication-title: Sleep Med. – volume: 86 start-page: 1698 year: 1989 end-page: 1702 ident: b0165 article-title: Stimulus-specific neuronal oscillations in orientation columns of cat visual cortex publication-title: Proc. Natl. Acad. Sci. – volume: 262 start-page: 8 year: 2014 end-page: 13 ident: b0550 article-title: The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy publication-title: Behav. Brain Res. – volume: 25 start-page: 231 year: 2004 end-page: 238 ident: b0375 article-title: The effect of age on prepro-orexin gene expression and contents of orexin A and B in the rat brain publication-title: Neurobiol. Aging – volume: 46 start-page: 297 year: 2005 end-page: 308 ident: b0410 article-title: Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice publication-title: Neuron – volume: 518 start-page: 389 year: 2010 end-page: 404 ident: b0565 article-title: Immunochemical characterization of inhibitory mouse cortical neurons: three chemically distinct classes of inhibitory cells publication-title: J. Comp. Neurol. – volume: 183 start-page: 123 year: 2007 end-page: 129 ident: b0235 article-title: Changes in rat olfactory detection performance induced by orexin and leptin mimicking fasting and satiation publication-title: Behav. Brain Res. – volume: 64 start-page: 614 year: 2012 end-page: 628 ident: b0310 article-title: Intranasal delivery of biologics to the central nervous system publication-title: Adv. Drug Deliv. Rev. – volume: 494 start-page: 57 year: 2011 end-page: 60 ident: b0385 article-title: Agonist ligand discrimination by the two orexin receptors depends on the expression system publication-title: Neurosci. Lett. – volume: 18 start-page: 9996 year: 1998 end-page: 10015 ident: b0370 article-title: Neurons containing hypocretin (orexin) project to multiple neuronal systems publication-title: J. Neurosci. – volume: 92 start-page: 573 year: 1998 end-page: 585 ident: b0405 article-title: Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior publication-title: Cell – volume: 34 start-page: 2832 year: 2014 end-page: 2844 ident: b0570 article-title: Cholinergic neurons excite cortically projecting basal forebrain GABAergic neurons publication-title: J. Neurosci. – volume: 89 start-page: 738 year: 1992 end-page: 742 ident: b0145 article-title: gamma-Aminobutyric acid-containing basal forebrain neurons innervate inhibitory interneurons in the neocortex publication-title: Proc. Natl. Acad. Sci. – volume: 195 start-page: 70 year: 2011 end-page: 79 ident: b0475 article-title: Aging-related alterations in orexin/hypocretin modulation of septo-hippocampal amino acid neurotransmission publication-title: Neuroscience – volume: 332 start-page: 190 year: 2002 end-page: 194 ident: b0500 article-title: Age-related decline in hypocretin (orexin) receptor 2 messenger RNA levels in the mouse brain publication-title: Neurosci. Lett. – volume: 95 start-page: 1656 year: 2006 end-page: 1668 ident: b0210 article-title: Prefrontal cortex-projecting glutamatergic thalamic paraventricular nucleus-excited by hypocretin: a feedforward circuit that may enhance cognitive arousal publication-title: J. Neurophysiol. – year: 2017 ident: b0055 article-title: Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin-A (hypocretin-1) publication-title: J. Neurochem. – start-page: 12 year: 2017 ident: b0525 article-title: Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicity publication-title: PLoS One – volume: 29 start-page: 693 year: 2008 end-page: 706 ident: b0100 article-title: Olfaction in patients with mild cognitive impairment and Alzheimer’s disease publication-title: Neurobiol. Aging – year: 2004 ident: b0280 article-title: Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders publication-title: Ageing Res. Rev. – volume: 8 start-page: 898 year: 2013 end-page: 903 ident: b0485 article-title: Discovery and characterization of ACT-335827, an orally available, brain penetrant orexin receptor type1 selective antagonist publication-title: ChemMedChem – volume: 63 start-page: 854 year: 2009 end-page: 864 ident: b0490 article-title: Representations of odor in the piriform cortex publication-title: Neuron – year: 2014 ident: b0340 article-title: Aging in the olfactory system publication-title: Trends Neurosci. – start-page: 9 year: 2008 ident: b0185 article-title: Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease publication-title: BMC Neurosci. – volume: 3 start-page: S3 year: 2002 end-page: S9 ident: b0400 article-title: Roles of orexins in the regulation of feeding and arousal publication-title: Sleep Med. – volume: 152 start-page: 785 year: 2008 end-page: 797 ident: b0515 article-title: Delivery of interferon-beta to the monkey nervous system following intranasal administration publication-title: Neuroscience – volume: 95 start-page: 1656 year: 2006 ident: 10.1016/j.brainres.2018.08.024_b0210 article-title: Prefrontal cortex-projecting glutamatergic thalamic paraventricular nucleus-excited by hypocretin: a feedforward circuit that may enhance cognitive arousal publication-title: J. Neurophysiol. doi: 10.1152/jn.00927.2005 – volume: 3 start-page: 23 year: 2000 ident: 10.1016/j.brainres.2018.08.024_b0225 article-title: Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs publication-title: Sleep Res. Online – volume: 481 start-page: 160 year: 2005 ident: 10.1016/j.brainres.2018.08.024_b0120 article-title: Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures publication-title: J. Comp. Neurol. doi: 10.1002/cne.20369 – volume: 34 start-page: 2832 year: 2014 ident: 10.1016/j.brainres.2018.08.024_b0570 article-title: Cholinergic neurons excite cortically projecting basal forebrain GABAergic neurons publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3235-13.2014 – volume: 26 start-page: 36 year: 2003 ident: 10.1016/j.brainres.2018.08.024_b0390 article-title: Attention deficits in patients with narcolepsy publication-title: Sleep – volume: 33 year: 2012 ident: 10.1016/j.brainres.2018.08.024_b0480 article-title: Interneuron loss reduces dendritic inhibition and GABA release in hippocampus of aged rats publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2010.12.014 – volume: 130 start-page: 541 year: 2005 ident: 10.1016/j.brainres.2018.08.024_b0135 article-title: Stimulation of cortical acetylcholine release by orexin A publication-title: Neuroscience doi: 10.1016/j.neuroscience.2004.09.050 – volume: 468 start-page: 51 year: 2010 ident: 10.1016/j.brainres.2018.08.024_b0420 article-title: Developmental and aging change of orexin-A and -B immunoreactive neurons in the male rat hypothalamus publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2009.10.061 – volume: 57 start-page: 263 year: 1992 ident: 10.1016/j.brainres.2018.08.024_b0240 article-title: Expression of c-fos and other genes encoding transcription factors in long-term potentiation. [Review] publication-title: Behav. Neural Biol. doi: 10.1016/0163-1047(92)90276-A – volume: 64 start-page: 614 year: 2012 ident: 10.1016/j.brainres.2018.08.024_b0310 article-title: Intranasal delivery of biologics to the central nervous system publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2011.11.002 – volume: 521 start-page: 1225 year: 2013 ident: 10.1016/j.brainres.2018.08.024_b0320 article-title: Distribution and intrinsic membrane properties of basal forebrain GABAergic and parvalbumin neurons in the mouse publication-title: J. Comp. Neurol. doi: 10.1002/cne.23290 – volume: 152 start-page: 785 year: 2008 ident: 10.1016/j.brainres.2018.08.024_b0515 article-title: Delivery of interferon-beta to the monkey nervous system following intranasal administration publication-title: Neuroscience doi: 10.1016/j.neuroscience.2008.01.013 – volume: 33 start-page: 1642 year: 2012 ident: 10.1016/j.brainres.2018.08.024_b0150 article-title: Hypocretin (orexin) loss in Alzheimer’s disease publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2011.03.014 – volume: 86 start-page: 1698 year: 1989 ident: 10.1016/j.brainres.2018.08.024_b0165 article-title: Stimulus-specific neuronal oscillations in orientation columns of cat visual cortex publication-title: Proc. Natl. Acad. Sci. doi: 10.1073/pnas.86.5.1698 – volume: 15 start-page: 329 year: 2006 ident: 10.1016/j.brainres.2018.08.024_b0355 article-title: Cognitive deficits in narcolepsy publication-title: J. Sleep Res. doi: 10.1111/j.1365-2869.2006.00533.x – volume: 18 start-page: 9996 year: 1998 ident: 10.1016/j.brainres.2018.08.024_b0370 article-title: Neurons containing hypocretin (orexin) project to multiple neuronal systems publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.18-23-09996.1998 – volume: 29 start-page: 693 year: 2008 ident: 10.1016/j.brainres.2018.08.024_b0100 article-title: Olfaction in patients with mild cognitive impairment and Alzheimer’s disease publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2006.11.014 – volume: 262 start-page: 8 year: 2014 ident: 10.1016/j.brainres.2018.08.024_b0550 article-title: The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2013.12.045 – volume: 1314 start-page: 112 year: 2010 ident: 10.1016/j.brainres.2018.08.024_b0125 article-title: Orexin/hypocretin modulation of the basal forebrain cholinergic system: role in attention publication-title: Brain Res. doi: 10.1016/j.brainres.2009.08.046 – volume: 198 start-page: 163 year: 2012 ident: 10.1016/j.brainres.2018.08.024_b0160 article-title: Orexin receptors as therapeutic drug targets publication-title: Prog. Brain Res. doi: 10.1016/B978-0-444-59489-1.00010-0 – volume: 233 start-page: 639 year: 2016 ident: 10.1016/j.brainres.2018.08.024_b0580 article-title: Orexin A-induced enhancement of attentional processing in rats: role of basal forebrain neurons publication-title: Psychopharmacology doi: 10.1007/s00213-015-4139-z – year: 1997 ident: 10.1016/j.brainres.2018.08.024_b0520 article-title: The transient 40-Hz response, mismatch negativity, and attentional processes in humans publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatry doi: 10.1016/S0278-5846(97)00077-8 – volume: 104 start-page: 1023 year: 2006 ident: 10.1016/j.brainres.2018.08.024_b0105 article-title: Orexins increase cortical acetylcholine release and electroencephalographic activation through orexin-1 receptor in the rat basal forebrain during isoflurane anesthesia publication-title: Anesthesiology doi: 10.1097/00000542-200605000-00019 – volume: 24 start-page: 8354 year: 2004 ident: 10.1016/j.brainres.2018.08.024_b0115 article-title: Aging results in reduced epidermal growth factor receptor signaling, diminished olfactory neurogenesis, and deficits in fine olfactory discrimination publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2751-04.2004 – volume: 28 start-page: 1286 year: 2007 ident: 10.1016/j.brainres.2018.08.024_b0110 article-title: Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque publication-title: Neurobiol. Aging doi: 10.1016/j.neurobiolaging.2006.05.025 – year: 1998 ident: 10.1016/j.brainres.2018.08.024_b0360 – volume: 2 year: 2012 ident: 10.1016/j.brainres.2018.08.024_b0460 article-title: Olfactory discrimination predicts cognitive decline among community-dwelling older adults publication-title: Transl. Psychiatry doi: 10.1038/tp.2012.43 – year: 2014 ident: 10.1016/j.brainres.2018.08.024_b0340 article-title: Aging in the olfactory system publication-title: Trends Neurosci. doi: 10.1016/j.tins.2013.11.004 – volume: 27 start-page: 14239 year: 2007 ident: 10.1016/j.brainres.2018.08.024_b0080 article-title: Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3878-07.2007 – year: 2009 ident: 10.1016/j.brainres.2018.08.024_b0085 article-title: Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system publication-title: J. Pharm. Sci. doi: 10.1002/jps.21604 – year: 2014 ident: 10.1016/j.brainres.2018.08.024_b0290 article-title: Orexin/hypocretin receptor signalling: a functional perspective publication-title: Br. J. Pharmacol. doi: 10.1111/bph.12296 – volume: 92 start-page: 573 year: 1998 ident: 10.1016/j.brainres.2018.08.024_b0405 article-title: Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior publication-title: Cell doi: 10.1016/S0092-8674(00)80949-6 – volume: 54 start-page: B492 year: 1999 ident: 10.1016/j.brainres.2018.08.024_b0530 article-title: Growth curves and survival characteristics of the animals used in the biomarkers of aging program publication-title: J. Gerontol. Ser. A Biol. Sci. Med. Sci. doi: 10.1093/gerona/54.11.B492 – volume: 198 start-page: 277 year: 2010 ident: 10.1016/j.brainres.2018.08.024_b0430 article-title: Orexins/hypocretins control bistability of hippocampal long-term synaptic plasticity through co-activation of multiple kinases publication-title: Acta Physiol. (Oxf) doi: 10.1111/j.1748-1716.2009.02021.x – volume: 171 start-page: 332 year: 2014 ident: 10.1016/j.brainres.2018.08.024_b0295 article-title: The hypocretins/orexins: integrators of multiple physiological functions publication-title: Br. J. Pharmacol. doi: 10.1111/bph.12415 – ident: 10.1016/j.brainres.2018.08.024_b0260 doi: 10.1093/cercor/7.6.476 – year: 2004 ident: 10.1016/j.brainres.2018.08.024_b0280 article-title: Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders publication-title: Ageing Res. Rev. doi: 10.1016/j.arr.2003.10.003 – volume: 518 start-page: 389 year: 2010 ident: 10.1016/j.brainres.2018.08.024_b0565 article-title: Immunochemical characterization of inhibitory mouse cortical neurons: three chemically distinct classes of inhibitory cells publication-title: J. Comp. Neurol. doi: 10.1002/cne.22229 – year: 2013 ident: 10.1016/j.brainres.2018.08.024_b0045 article-title: Neurons and circuits for odor processing in the piriform cortex publication-title: Trends Neurosci. doi: 10.1016/j.tins.2013.04.005 – volume: 13 start-page: 111 year: 2003 ident: 10.1016/j.brainres.2018.08.024_b0010 article-title: Development of an orexin-2 receptor selective agonist, [Ala11, D-Leu15]orexin-B publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/S0960-894X(02)00851-X – volume: 59 start-page: 504 year: 2016 ident: 10.1016/j.brainres.2018.08.024_b0395 article-title: Orexin receptor antagonists: new therapeutic agents for the treatment of insomnia publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.5b00832 – year: 2017 ident: 10.1016/j.brainres.2018.08.024_b0055 article-title: Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin-A (hypocretin-1) publication-title: J. Neurochem. – year: 2008 ident: 10.1016/j.brainres.2018.08.024_b0180 article-title: Revealing the potential of intranasally administered orexin A publication-title: Mol. Interventions doi: 10.1124/mi.8.3.5 – volume: 95 start-page: 322 year: 1998 ident: 10.1016/j.brainres.2018.08.024_b0075 article-title: The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.95.1.322 – volume: 289 start-page: 219 year: 1999 ident: 10.1016/j.brainres.2018.08.024_b0255 article-title: Orexin A but not orexin B rapidly enters brain from blood by simple diffusion publication-title: J. Pharmacol. Exp. Ther. doi: 10.1016/S0022-3565(24)38126-1 – volume: 326 start-page: 1005 year: 2009 ident: 10.1016/j.brainres.2018.08.024_b0245 article-title: Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle publication-title: Science doi: 10.1126/science.1180962 – volume: 127 start-page: 481 year: 2004 ident: 10.1016/j.brainres.2018.08.024_b0510 article-title: Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration publication-title: Neuroscience doi: 10.1016/j.neuroscience.2004.05.029 – volume: 49 start-page: 589 year: 2006 ident: 10.1016/j.brainres.2018.08.024_b0050 article-title: Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine publication-title: Neuron doi: 10.1016/j.neuron.2006.01.016 – volume: 162 start-page: 1287 year: 2009 ident: 10.1016/j.brainres.2018.08.024_b0380 article-title: Nutritional status modulates behavioural and olfactory bulb Fos responses to isoamyl acetate or food odour in rats: roles of orexins and leptin publication-title: Neuroscience doi: 10.1016/j.neuroscience.2009.05.043 – volume: 31 start-page: 384 year: 2006 ident: 10.1016/j.brainres.2018.08.024_b0540 article-title: Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300807 – volume: 110 issue: 1–7 year: 2013 ident: 10.1016/j.brainres.2018.08.024_b0215 article-title: Olfactory dysfunction: common in later life and early warning of neurodegenerative disease publication-title: Dtsch. Arztebl. Int. – volume: 31 start-page: 6518 year: 2011 ident: 10.1016/j.brainres.2018.08.024_b0330 article-title: Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.6506-10.2011 – year: 2013 ident: 10.1016/j.brainres.2018.08.024_b0335 article-title: Orexin (Hypocretin) receptor agonists and antagonists for treatment of sleep disorders: rationale for development and current status publication-title: CNS Drugs doi: 10.1007/s40263-012-0036-8 – volume: 494 start-page: 845 year: 2006 ident: 10.1016/j.brainres.2018.08.024_b0575 article-title: Afferents to the orexin neurons of the rat brain publication-title: J. Comp. Neurol. doi: 10.1002/cne.20859 – volume: 345 year: 2014 ident: 10.1016/j.brainres.2018.08.024_b0205 article-title: Fast-spiking, parvalbumin+ GABAergic interneurons: from cellular design to microcircuit function publication-title: Science (80-.) doi: 10.1126/science.1255263 – volume: 3 start-page: S3 issue: Suppl. 2 year: 2002 ident: 10.1016/j.brainres.2018.08.024_b0400 article-title: Roles of orexins in the regulation of feeding and arousal publication-title: Sleep Med. doi: 10.1016/S1389-9457(02)00156-9 – volume: 8 start-page: 898 year: 2013 ident: 10.1016/j.brainres.2018.08.024_b0485 article-title: Discovery and characterization of ACT-335827, an orally available, brain penetrant orexin receptor type1 selective antagonist publication-title: ChemMedChem doi: 10.1002/cmdc.201300003 – volume: 1129 start-page: 26 year: 2008 ident: 10.1016/j.brainres.2018.08.024_b0230 article-title: Modulation of cortical activation and behavioral arousal by cholinergic and orexinergic systems publication-title: Mol. Biophys. Mech. Arousal, Alertness, Atten. – start-page: 12 year: 2017 ident: 10.1016/j.brainres.2018.08.024_b0525 article-title: Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicity publication-title: PLoS One – volume: 33 start-page: 283 year: 2017 ident: 10.1016/j.brainres.2018.08.024_b0030 article-title: Hypocretin/orexin and plastic adaptations associated with drug abuse publication-title: Curr. Top. Behav. Neurosci. doi: 10.1007/7854_2016_44 – start-page: 9 year: 2008 ident: 10.1016/j.brainres.2018.08.024_b0185 article-title: Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease publication-title: BMC Neurosci. – volume: 195 start-page: 70 year: 2011 ident: 10.1016/j.brainres.2018.08.024_b0475 article-title: Aging-related alterations in orexin/hypocretin modulation of septo-hippocampal amino acid neurotransmission publication-title: Neuroscience doi: 10.1016/j.neuroscience.2011.08.033 – volume: 30 start-page: 505 year: 2010 ident: 10.1016/j.brainres.2018.08.024_b0555 article-title: Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer’s disease mouse model publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4622-09.2010 – volume: 26 start-page: 953 year: 2003 ident: 10.1016/j.brainres.2018.08.024_b0155 article-title: Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog publication-title: Sleep doi: 10.1093/sleep/26.8.953 – volume: 627 start-page: 155 year: 2016 ident: 10.1016/j.brainres.2018.08.024_b0095 article-title: Food consumption and activity levels increase in rats following intranasal Hypocretin-1 publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2016.05.053 – volume: 17 start-page: 780 year: 2015 ident: 10.1016/j.brainres.2018.08.024_b0325 article-title: Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases publication-title: AAPS J. doi: 10.1208/s12248-015-9719-7 – volume: 22 start-page: 7754 year: 2002 ident: 10.1016/j.brainres.2018.08.024_b0560 article-title: Hypocretin increases impulse flow in the septohippocampal GABAergic pathway: implications for arousal via a mechanism of hippocampal disinhibition publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.22-17-07754.2002 – volume: 51 start-page: B54 year: 1996 ident: 10.1016/j.brainres.2018.08.024_b0305 article-title: Pathologic characterization of brown Norway, brown Norway x Fischer 344, and Fischer 344 x brown Norway rats with relation to age publication-title: J. Gerontol. A Biol. Sci. Med. Sci. doi: 10.1093/gerona/51A.1.B54 – volume: 5 start-page: 12584 year: 2015 ident: 10.1016/j.brainres.2018.08.024_b0070 article-title: Orexin receptors exert a neuroprotective effect in Alzheimer’s disease (AD) via heterodimerization with GPR103 publication-title: Sci. Rep. doi: 10.1038/srep12584 – volume: 350 start-page: 124 year: 2017 ident: 10.1016/j.brainres.2018.08.024_b0175 article-title: Upregulation of orexin/hypocretin expression in aged rats: Effects on feeding latency and neurotransmission in the insular cortex publication-title: Neuroscience doi: 10.1016/j.neuroscience.2017.03.021 – volume: 930 start-page: 206 year: 2002 ident: 10.1016/j.brainres.2018.08.024_b0585 article-title: Age-related changes in hypocretin (orexin) immunoreactivity in the cat brainstem publication-title: Brain Res. doi: 10.1016/S0006-8993(02)02240-0 – volume: 112 start-page: 3535 year: 2015 ident: 10.1016/j.brainres.2018.08.024_b0275 article-title: Cortically projecting basal forebrain parvalbumin neurons regulate cortical gamma band oscillations publication-title: Proc. Natl. Acad. Sci. doi: 10.1073/pnas.1413625112 – volume: 46 start-page: 297 year: 2005 ident: 10.1016/j.brainres.2018.08.024_b0410 article-title: Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice publication-title: Neuron doi: 10.1016/j.neuron.2005.03.010 – volume: 183 start-page: 123 year: 2007 ident: 10.1016/j.brainres.2018.08.024_b0235 article-title: Changes in rat olfactory detection performance induced by orexin and leptin mimicking fasting and satiation publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2007.05.033 – volume: 332 start-page: 190 year: 2002 ident: 10.1016/j.brainres.2018.08.024_b0500 article-title: Age-related decline in hypocretin (orexin) receptor 2 messenger RNA levels in the mouse brain publication-title: Neurosci. Lett. doi: 10.1016/S0304-3940(02)00953-9 – volume: 435 start-page: 6 year: 2001 ident: 10.1016/j.brainres.2018.08.024_b0315 article-title: Differential expression of orexin receptors 1 and 2 in the rat brain publication-title: J. Comp. Neurol. doi: 10.1002/cne.1190 – volume: 27 start-page: 1364 year: 2017 ident: 10.1016/j.brainres.2018.08.024_b0440 article-title: Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2017.02.012 – volume: 63 start-page: 854 year: 2009 ident: 10.1016/j.brainres.2018.08.024_b0490 article-title: Representations of odor in the piriform cortex publication-title: Neuron doi: 10.1016/j.neuron.2009.09.005 – volume: 131 start-page: 2734 year: 2008 ident: 10.1016/j.brainres.2018.08.024_b0020 article-title: Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1) publication-title: Brain doi: 10.1093/brain/awn193 – volume: 459 start-page: 698 year: 2009 ident: 10.1016/j.brainres.2018.08.024_b0455 article-title: Parvalbumin neurons and gamma rhythms enhance cortical circuit performance publication-title: Nature doi: 10.1038/nature07991 – volume: 149 start-page: 499 year: 2007 ident: 10.1016/j.brainres.2018.08.024_b0140 article-title: Food-elicited increases in cortical acetylcholine release require orexin transmission publication-title: Neuroscience doi: 10.1016/j.neuroscience.2007.07.061 – volume: 38 start-page: 2150 year: 2017 ident: 10.1016/j.brainres.2018.08.024_b0015 article-title: Convergent gustatory and viscerosensory processing in the human dorsal mid-insula publication-title: Hum. Brain Mapp. doi: 10.1002/hbm.23510 – volume: 132 start-page: 1179 year: 2001 ident: 10.1016/j.brainres.2018.08.024_b0450 article-title: SB-334867-A: the first selective orexin-1 receptor antagonist publication-title: Br. J. Pharmacol. doi: 10.1038/sj.bjp.0703953 – volume: 122 start-page: 383 issue: Pt 3 year: 1999 ident: 10.1016/j.brainres.2018.08.024_b0365 article-title: Attention and executive deficits in Alzheimer’s disease. A critical review publication-title: Brain doi: 10.1093/brain/122.3.383 – volume: 3 start-page: 19 year: 2013 ident: 10.1016/j.brainres.2018.08.024_b0265 article-title: Development and specification of GABAergic cortical interneurons publication-title: Cell Biosci. doi: 10.1186/2045-3701-3-19 – volume: 11 start-page: 876 year: 2010 ident: 10.1016/j.brainres.2018.08.024_b0040 article-title: Olfactory dysfunction in narcolepsy with cataplexy publication-title: Sleep Med. doi: 10.1016/j.sleep.2010.07.004 – volume: 25 start-page: 5225 year: 2005 ident: 10.1016/j.brainres.2018.08.024_b0285 article-title: Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0719-05.2005 – volume: 25 start-page: 231 year: 2004 ident: 10.1016/j.brainres.2018.08.024_b0375 article-title: The effect of age on prepro-orexin gene expression and contents of orexin A and B in the rat brain publication-title: Neurobiol. Aging doi: 10.1016/S0197-4580(03)00043-5 – volume: 305 start-page: 507 year: 2003 ident: 10.1016/j.brainres.2018.08.024_b0005 article-title: Distinct recognition of OX1 and OX2 receptors by orexin peptides publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.102.048025 – volume: 111 start-page: 379 year: 2002 ident: 10.1016/j.brainres.2018.08.024_b0130 article-title: Anatomical substrates of orexin-dopamine interactions: Lateral hypothalamic projections to the ventral tegmental area publication-title: Neuroscience doi: 10.1016/S0306-4522(02)00017-9 – volume: 7 start-page: 27 year: 2016 ident: 10.1016/j.brainres.2018.08.024_b0350 article-title: A simple practice guide for dose conversion between animals and human publication-title: J. Basic Clin. Pharm. doi: 10.4103/0976-0105.177703 – year: 1999 ident: 10.1016/j.brainres.2018.08.024_b0435 article-title: Narcolepsy: a key role for hypocretins (Orexins) publication-title: Cell doi: 10.1016/S0092-8674(00)81969-8 – volume: 27 start-page: 654 year: 2008 ident: 10.1016/j.brainres.2018.08.024_b0195 article-title: Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons publication-title: Eur. J. Neurosci. doi: 10.1111/j.1460-9568.2008.06029.x – volume: 494 start-page: 57 year: 2011 ident: 10.1016/j.brainres.2018.08.024_b0385 article-title: Agonist ligand discrimination by the two orexin receptors depends on the expression system publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2011.02.055 – volume: 12 start-page: 941 year: 2011 ident: 10.1016/j.brainres.2018.08.024_b0025 article-title: Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy publication-title: Sleep Med. doi: 10.1016/j.sleep.2011.06.015 – volume: 569 start-page: 68 year: 2014 ident: 10.1016/j.brainres.2018.08.024_b0250 article-title: Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2014.03.020 – volume: 27 start-page: 389 year: 2018 ident: 10.1016/j.brainres.2018.08.024_b0495 article-title: An overview of hypocretin based therapy in narcolepsy publication-title: Expert Opin. Invest. Drugs doi: 10.1080/13543784.2018.1459561 – volume: 89 start-page: 738 year: 1992 ident: 10.1016/j.brainres.2018.08.024_b0145 article-title: gamma-Aminobutyric acid-containing basal forebrain neurons innervate inhibitory interneurons in the neocortex publication-title: Proc. Natl. Acad. Sci. doi: 10.1073/pnas.89.2.738 – volume: 33 start-page: 305 year: 2017 ident: 10.1016/j.brainres.2018.08.024_b0300 article-title: Orexin and Alzheimer’s disease publication-title: Curr. Top. Behav. Neurosci. doi: 10.1007/7854_2016_50 – volume: 58 start-page: 7931 year: 2015 ident: 10.1016/j.brainres.2018.08.024_b0345 article-title: Design and synthesis of non-peptide, selective orexin receptor 2 agonists publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.5b00988 – year: 2002 ident: 10.1016/j.brainres.2018.08.024_b0415 article-title: Age- and dementia-associated impairments in divided attention: psychological constructs, animal models, and underlying neuronal mechanisms publication-title: Dement. Geriatr. Cogn. Disord. doi: 10.1159/000048633 – volume: 399 start-page: 101 year: 2006 ident: 10.1016/j.brainres.2018.08.024_b0465 article-title: Modulatory effects of hypocretin-1/orexin-A with glutamate and gamma-aminobutyric acid on freshly isolated pyramidal neurons from the rat prefrontal cortex publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2006.01.065 – volume: 12 start-page: 2767 year: 2015 ident: 10.1016/j.brainres.2018.08.024_b0470 article-title: Intranasal neuropeptide administration to target the human brain in health and disease publication-title: Mol. Pharm. doi: 10.1021/acs.molpharmaceut.5b00047 – year: 2017 ident: 10.1016/j.brainres.2018.08.024_b0190 article-title: The insular cortex dynamically maps changes in cardiorespiratory interoception publication-title: Neuropsychopharmacology – volume: 32 start-page: 993 year: 2009 ident: 10.1016/j.brainres.2018.08.024_b0505 article-title: Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy publication-title: Sleep doi: 10.1093/sleep/32.8.993 – volume: 114 start-page: 5731 year: 2017 ident: 10.1016/j.brainres.2018.08.024_b0220 article-title: Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.1700499114 – volume: 11 year: 2017 ident: 10.1016/j.brainres.2018.08.024_b0535 article-title: Basal forebrain cholinergic system and orexin neurons: effects on attention publication-title: Front. Behav. Neurosci. doi: 10.3389/fnbeh.2017.00010 – year: 2002 ident: 10.1016/j.brainres.2018.08.024_b0445 article-title: The physiology and pharmacology of the orexins publication-title: Pharmacol. Ther. doi: 10.1016/S0163-7258(02)00171-7 – volume: 464 start-page: 220 year: 2003 ident: 10.1016/j.brainres.2018.08.024_b0035 article-title: Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress publication-title: J. Comp. Neurol. doi: 10.1002/cne.10783 – volume: 99 start-page: 1654 year: 2010 ident: 10.1016/j.brainres.2018.08.024_b0090 article-title: Intranasal delivery to the central nervous system: mechanisms and experimental considerations publication-title: J. Pharm. Sci. doi: 10.1002/jps.21924 – volume: 23 start-page: 291 year: 2014 ident: 10.1016/j.brainres.2018.08.024_b0545 article-title: Improvement of divided attention in narcolepsy by intranasal orexin-A publication-title: J. Sleep Res. – volume: 127 start-page: 519 year: 2004 ident: 10.1016/j.brainres.2018.08.024_b0425 article-title: Orexins/hypocretins cause sharp wave- and θ-related synaptic plasticity in the hippocampus via glutamatergic, gabaergic, noradrenergic, and cholinergic signaling publication-title: Neuroscience doi: 10.1016/j.neuroscience.2004.05.012 – year: 2017 ident: 10.1016/j.brainres.2018.08.024_b0060 article-title: Orexin system: the key for a healthy life publication-title: Front. Neurol. – volume: 3 start-page: 655 year: 2002 ident: 10.1016/j.brainres.2018.08.024_b0065 article-title: How do you feel? Interoception: the sense of the physiological condition of the body publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn894 – volume: 458 start-page: 11 year: 2003 ident: 10.1016/j.brainres.2018.08.024_b0170 article-title: Parvalbumin, calbindin, or calretinin in cortically projecting and GABAergic, cholinergic, or glutamatergic basal forebrain neurons of the rat publication-title: J. Comp. Neurol. doi: 10.1002/cne.10505 – volume: 178 start-page: 82 year: 2011 ident: 10.1016/j.brainres.2018.08.024_b0270 article-title: Age-related loss of orexin/hypocretin neurons publication-title: Neuroscience doi: 10.1016/j.neuroscience.2011.01.031 – volume: 415 start-page: 145 year: 1999 ident: 10.1016/j.brainres.2018.08.024_b0200 article-title: Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system publication-title: J. Comp. Neurol. doi: 10.1002/(SICI)1096-9861(19991213)415:2<145::AID-CNE1>3.0.CO;2-2 |
| SSID | ssj0003390 |
| Score | 2.401889 |
| SecondaryResourceType | review_article |
| Snippet | •Impaired orexin signaling is implicated in several neuropsychiatric conditions.•Intranasal orexin targets brain regions and neurotransmitters implicated in... Cognitive impairment is a core feature of several neuropsychiatric and neurological disorders, including narcolepsy and age-related dementias. Current... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 145921 |
| SubjectTerms | Administration, Intranasal Aging - physiology Aging - psychology Animals Basal Forebrain - drug effects Basal Forebrain - physiology Brain - drug effects Brain - physiology Cholinergic Neurons - drug effects Cholinergic Neurons - physiology Cognitive Dysfunction - physiopathology Cognitive Dysfunction - prevention & control Humans Neurons - drug effects Neurons - physiology Orexins - administration & dosage Orexins - physiology |
| Title | Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0006899318304463 https://dx.doi.org/10.1016/j.brainres.2018.08.024 https://www.ncbi.nlm.nih.gov/pubmed/30148983 https://www.proquest.com/docview/2095542277 https://pubmed.ncbi.nlm.nih.gov/PMC6387866 |
| Volume | 1731 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEBYhvfRS2qaP7SOoUHpzNtbbvS1Lw6ZtQikN5GZka0wdEnuJN5Bc8tsz41d3W0oKPRlsjZCl0Tykb2YYe2_dvvAQF5HzFiKlCh8lQfooC7HRWZEoAXSgf3RsFifq86k-3WLzIRaGYJW97O9keiut-zfTfjany7KkGN99g94CMSXdSlLGT6Uscfne7S-Yh5TdOQt5ztR6LUr4bC-jMgzo1hLEy7WpPIX6m4L60wD9HUe5ppgOHrNHvUXJZ92gn7AtqJ6ynVmF3vTFDf_AW4xne3i-w64PqYvKN0jgN9Lm8rrg9SVclxVfEtAlQPORHwHFBZfNRcN9FfharBZf1ivCGWE_aPVyFEpRGxUDgY-AJB5uGlKb1P0zdnLw6cd8EfW1F6JcC7OKwEpPQa0eV6sQhdW5lioEEwcdyyDi4HQGALpIYhfAotEH0rvMmSIJSRZy-ZxtV3UFLxnPEydlpgvlg1d5MMgUMlMm9mhMOchhwvQw4WneJyan-hjn6YBAO0uHhUppoVIqnCnUhE1HumWXmuNeCjusZzoEnqKoTFF73EuZjJQb7PlPtO8G1klx79KFjK-gvqJGCVpzQlg7YS86Vhr_hFxdhzOHY95gsrEB5QXf_FKVP9v84ChSrTPm1X-M-TV7KOhggYCL-g3bXl1ewVu0vlbZbru9dtmD2fz712_0PPyyOL4DKUE4Cw |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9RADB6V7QEuqFAeCwUGCXEL28wrk95WFdUu7e6plXqLJhlHpKLJqtlK7b_Hzku7RahIXJN4NBl7PLbns83Yl8geCgdhHlgXQaBU7oLYSxekPjQ6zWMlgAL6i6WZXagfl_pyhx33uTAEq-x0f6vTG23dPZl0qzlZFQXl-B4a9BZIKOlWUj5hu1SdSo_Y7nR-OlsOClnKNtRCzjMRbCQKX31LqRMDeraE8rJNNU-h_nZG_WmDPoRSbpxNJ3vseWdU8mk77xdsB8qXbH9aokN9fc-_8gbm2cTP99ndnIYoXY0EbqtyLq9yXt3AXVHyFWFdPNRHfAGUGlzU1zV3pecb6Vp8Va0JaoTjoOHLUS8FTWIMeD5gkri_r-nkpOFfsYuT7-fHs6BrvxBkWph1AJF0lNfqkGG5yCOdaam8N6HXofQi9FanAKDzOLQeIrT7QDqbWpPHPk59Jl-zUVmV8JbxLLZSpjpXzjuVeYNyIVNlQof2lIUMxkz3C55kXW1yapHxK-lBaFdJz6iEGJVQ70yhxmwy0K3a6hyPUkQ9P5M-9xS1ZYIHyKOU8UC5JaH_RPu5F50Ety_dybgSqlv6KEaDTogoGrM3rSgNf0LersWVwzlvCdnwAZUG335TFj-bEuGoVSNrzLv_mPMn9nR2vjhLzubL0_fsmaA4A-EY9QEbrW9u4QMaY-v0Y7fZfgPkeTkn |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intranasal+administration+of+orexin+peptides%3A+Mechanisms+and+therapeutic+potential+for+age-related+cognitive+dysfunction&rft.jtitle=Brain+research&rft.au=Calva%2C+Coleman+B&rft.au=Fadel%2C+Jim+R&rft.date=2020-03-15&rft.eissn=1872-6240&rft.volume=1731&rft.spage=145921&rft_id=info:doi/10.1016%2Fj.brainres.2018.08.024&rft_id=info%3Apmid%2F30148983&rft.externalDocID=30148983 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-8993&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-8993&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-8993&client=summon |